Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2013

May 17, 2013

30198_dirs_2013-05-17_eae619f4-9182-4d02-a61a-ef56c993612a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-05-15

Reporting Person: MOY JEFFREY (SVP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-15 Common Stock M 5000 $3.19 Acquired 199248 Direct
2013-05-15 Common Stock S 5000 $19.9745 Disposed 194248 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-05-15 Non-Qualified Stock Option (right to buy) $3.19 M 5000 Disposed 2018-12-11 Common Stock (5000) Direct

Footnotes

F1: Included in this number are 104,291 unvested restricted stock units, 50,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016, 29,166 of which were granted on March 8, 2012 and shall vest through March 8, 2015, and 25,125 of which were granted on March 8, 2011 and shall vest through March 8, 2014.